98 related articles for article (PubMed ID: 8806895)
1. Central and regional hemodynamic effects during infusion of Big endothelin-1 in healthy humans.
Ahlborg G; Ottosson-Seeberger A; Hemsén A; Lundberg JM
J Appl Physiol (1985); 1996 Jun; 80(6):1921-7. PubMed ID: 8806895
[TBL] [Abstract][Full Text] [Related]
2. Big ET-1 infusion in man causes renal ET-1 release, renal and splanchnic vasoconstriction, and increased mean arterial blood pressure.
Ahlborg G; Ottosson-Seeberger A; Hemsén A; Lundberg JM
Cardiovasc Res; 1994 Oct; 28(10):1559-63. PubMed ID: 8001046
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal fragment of big endothelin-1 does not potentiate the vasoactive effects of endothelin-1.
Ottosson-Seeberger A; Hemsén A; Lundberg JM; Ahlborg G
Clin Physiol; 1998 Jan; 18(1):61-8. PubMed ID: 9545622
[TBL] [Abstract][Full Text] [Related]
4. Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock.
Weitzberg E; Hemsén A; Rudehill A; Modin A; Wanecek M; Lundberg JM
Br J Pharmacol; 1996 Jun; 118(3):617-26. PubMed ID: 8762086
[TBL] [Abstract][Full Text] [Related]
5. Regional extraction of endothelins and conversion of big endothelin to endothelin-1 in the pig.
Hemsén A; Pernow J; Lundberg JM
Acta Physiol Scand; 1991 Mar; 141(3):325-34. PubMed ID: 1858505
[TBL] [Abstract][Full Text] [Related]
6. Comparable potent coronary constrictor effects of endothelin-1 and big endothelin-1 in humans.
Pernow J; Kaijser L; Lundberg JM; Ahlborg G
Circulation; 1996 Nov; 94(9):2077-82. PubMed ID: 8901654
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of endothelin-1 and big endothelin-1 in chronic hemodialysis patients.
Ottosson-Seeberger A; Ahlborg G; Hemsén A; Lundberg JM; Alvestrand A
J Am Soc Nephrol; 1999 May; 10(5):1037-44. PubMed ID: 10232690
[TBL] [Abstract][Full Text] [Related]
8. Differences in vascular effects and removal of endothelin-1 in human lung, brain, and skeletal muscle.
Weitzberg E; Ahlborg G; Lundberg JM
Clin Physiol; 1993 Nov; 13(6):653-62. PubMed ID: 8119059
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs.
Teerlink JR; Carteaux JP; Sprecher U; Löffler BM; Clozel M; Clozel JP
Am J Physiol; 1995 Jan; 268(1 Pt 2):H432-40. PubMed ID: 7840293
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the hemodynamic effects of endothelin-1 and big endothelin-1 in the rat.
Pollock DM; Opgenorth TJ
Biochem Biophys Res Commun; 1991 Sep; 179(2):1122-6. PubMed ID: 1898393
[TBL] [Abstract][Full Text] [Related]
11. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.
Ivy DD; Kinsella JP; Abman SH
J Clin Invest; 1994 May; 93(5):2141-8. PubMed ID: 8182146
[TBL] [Abstract][Full Text] [Related]
12. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
[TBL] [Abstract][Full Text] [Related]
13. Analysis of responses to big endothelin in the hindquarters vascular bed of the cat.
Tamura DY; Minkes RK; Bellan JA; McMahon TJ; McNamara DB; Kadowitz PJ
Can J Cardiol; 1992 Nov; 8(9):954-60. PubMed ID: 1486546
[TBL] [Abstract][Full Text] [Related]
14. Comparison of responses to sarafotoxins 6a and 6c in pulmonary and systemic vascular beds.
Minkes RK; Bellan JA; Higuera TR; Kadowitz PJ
Am J Physiol; 1992 Mar; 262(3 Pt 2):H852-61. PubMed ID: 1348398
[TBL] [Abstract][Full Text] [Related]
15. The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044.
Plumpton C; Ferro CJ; Haynes WG; Webb DJ; Davenport AP
Br J Pharmacol; 1996 Sep; 119(2):311-4. PubMed ID: 8886414
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of Big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21).
Hemsén A; Ahlborg G; Ottosson-Seeberger A; Lundberg JM
Regul Pept; 1995 Feb; 55(3):287-97. PubMed ID: 7761628
[TBL] [Abstract][Full Text] [Related]
17. Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
Ferro CJ; Strachan FE; Shepherd E; Haynes WG; Webb DJ
Clin Pharmacol Ther; 2000 Jul; 68(1):67-74. PubMed ID: 10945317
[TBL] [Abstract][Full Text] [Related]
18. Opposite effects of endothelin-1 and Big-endothelin-(1-39) on renal function in rats.
Hoffman A; Grossman E; Keiser HR
Eur J Pharmacol; 1990 Jul; 182(3):603-6. PubMed ID: 2226627
[TBL] [Abstract][Full Text] [Related]
19. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
[TBL] [Abstract][Full Text] [Related]
20. Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans.
Ahlborg G; Lindström J
J Appl Physiol (1985); 2002 Dec; 93(6):2112-21. PubMed ID: 12391119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
